BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9112457)

  • 1. Impact of radiation therapy fraction size on local control of early glottic carcinoma.
    Yu E; Shenouda G; Beaudet MP; Black MJ
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):587-91. PubMed ID: 9112457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
    Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
    Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of early and moderately advanced vocal cord carcinoma with 6-MV X-rays.
    Parsons JT; Greene BD; Speer TW; Kirkpatrick SA; Barhorst DB; Yanckowitz T
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):953-9. PubMed ID: 11429223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control.
    Sakata K; Aoki Y; Karasawa K; Hasezawa K; Muta N; Nakagawa K; Terahara A; Onogi Y; Sasaki Y; Akanuma A
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1059-64. PubMed ID: 7961012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control.
    Fein DA; Mendenhall WM; Parsons JT; Million RR
    Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):605-11. PubMed ID: 8454477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution.
    Laskar SG; Baijal G; Murthy V; Chilukuri S; Budrukkar A; Gupta T; Agarwal JP
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e180-6. PubMed ID: 22862908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
    van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
    Garden AS; Morrison WH; Ang KK; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
    Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T1 glottic carcinoma involving the posterior commissure.
    Shvero J; Shvili I; Mizrachi A; Shpitzer T; Nageris B; Koren R; Hadar T
    Laryngoscope; 2009 Jun; 119(6):1116-9. PubMed ID: 19308987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
    Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
    Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral stage Ib glottic carcinoma: results of radiation therapy.
    Sinha PP
    Radiology; 1988 Dec; 169(3):835-8. PubMed ID: 3187008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study.
    Moon SH; Cho KH; Chung EJ; Lee CG; Lee KC; Chai GY; Kang KM; Lee JY; Chung WK; Park WY; Kim JH
    Radiother Oncol; 2014 Jan; 110(1):98-103. PubMed ID: 24161568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients.
    Marshak G; Brenner B; Shvero J; Shapira J; Ophir D; Hochman I; Marshak G; Sulkes A; Rakowsky E
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1009-13. PubMed ID: 10192348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive radiotherapy for carcinoma in situ of the true vocal cords.
    Sengupta N; Morris CG; Kirwan J; Amdur RJ; Mendenhall WM
    Am J Clin Oncol; 2010 Feb; 33(1):94-5. PubMed ID: 19738453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx?
    Fein DA; Lee WR; Hanlon AL; Ridge JA; Curran WJ; Coia LR
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):823-31. PubMed ID: 8598359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
    Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS
    Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience.
    Gowda RV; Henk JM; Mais KL; Sykes AJ; Swindell R; Slevin NJ
    Radiother Oncol; 2003 Aug; 68(2):105-11. PubMed ID: 12972304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.
    Lee JH; Machtay M; McKenna MG; Weinstein GS; Markiewicz DA; Krisch RE; Kligerman MM
    Am J Otolaryngol; 2001; 22(1):43-54. PubMed ID: 11172214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.